REQUEST A DEMO
Total
USD $0.00
Search more companies

Sinopharm Group Company Limited (国药控股股份有限公司) (China)

Main Activities: Pharmaceutical and Medicine Manufacturing | Pharmaceutical Preparation Manufacturing
Full name: Sinopharm Group Company Limited Profile Updated: January 09, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

Sinopharm Group Company Limited (国药控股股份有限公司) is an enterprise located in China, with the main office in Hong Kong. It operates in the Pharmaceutical and Medicine Manufacturing industry. The company was established on October 06, 2008. It currently has a total number of 108,217 (2024) employees. There was a net sales revenue drop of 2.95% reported in Sinopharm Group Company Limited (国药控股股份有限公司)’s latest financial highlights for Q2C2025. Its total assets decreased by 2.15% over the same period. The net profit margin of Sinopharm Group Company Limited (国药控股股份有限公司) decreased by 0.13% in 2025.

Headquarters
Unit B2-A, 20/F, Far East Finance Centre, 16 Harcourt Road
Hong Kong; Hong Kong;

Contact Details: Purchase the Sinopharm Group Company Limited (国药控股股份有限公司) report to view the information.

Website: http://www.sinopharmgroup.com.cn

Basic Information
Total Employees:
Purchase the Sinopharm Group Company Limited (国药控股股份有限公司) report to view the information.
Outstanding Shares:
Purchase the Sinopharm Group Company Limited (国药控股股份有限公司) report to view the information.
Registered Capital:
Purchase the Sinopharm Group Company Limited (国药控股股份有限公司) report to view the information.
Financial Auditors:
Purchase the Sinopharm Group Company Limited (国药控股股份有限公司) report to view the information.
Incorporation Date:
October 06, 2008
Key Executives
Purchase this report to view the information.
Vice Chairman
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
1.18%
Purchase this report to view the information.
0.08%
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Beijing Sinopharm Tianyuan Real Estate Property Management Co., Ltd.
100%
China National Pharmaceutica Group Shanghai Likang Medicine Co., Ltd.
100%
Guangdong Dong Fang New Special Drugs Corporation
100%
Company Performance
Financial values in the chart are available after Sinopharm Group Company Limited (国药控股股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-2.95%
Total Operating Revenue
-2.89%
Operating Profit
-3.04%
EBITDA
-5.17%
Net Profit/Loss for the Period
-9.53%
Total Assets
-2.15%
Total Equity
5.58%
Operating Profit Margin
0%
Net Profit Margin
-0.13%
Return on Equity (ROE)
-0.69%
Debt / Equity
-11610%
Quick Ratio
-4.99%
Cash Ratio
-0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?